Engineered B Cell Medicine Gets Orphan Drug Status for Hemophilia B

BE-101 is a potential first-in-class B cell medicine engineered to insert the human FIX gene into primary human B cells.

Related Keywords

Joanne Smith Farrell ,Drug Administration ,Orphan Drug ,